Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium vivax heme detoxification pathway is a critical metabolic process in malaria parasites, responsible for neutralizing the toxic heme released during hemoglobin digestion inside infected red blood cells. As the parasite digests host hemoglobin, large amounts of free heme are liberated; this molecule is highly toxic due to its capacity to generate free radicals and peroxidative cellular damage. To avoid heme-mediated toxicity, Plasmodium species convert free heme into an insoluble crystalline material called hemozoin. This transformation occurs mainly in the parasite's digestive vacuole and involves several proteins, notably Heme Detoxification Protein (HDP) and falcipain-family proteases[1][5][7]. The heme detoxification pathway is a central and validated antimalarial drug target, with several major drug classes (e.g., chloroquine, artemisinin, and related compounds) exerting their antimalarial activity by inhibiting hemozoin formation, complexing with heme, or disrupting heme processing[2][4][6][8]. Disruption of this pathway leads to toxic heme accumulation, oxidative stress, and parasite death. The molecular details of hemozoin formation and the full complement of involved proteins remain areas of active research, particularly as drug-resistant malaria strains emerge. While most current drugs are directed at the P. falciparum pathway, the same fundamental process is essential in P. vivax, making this pathway universally relevant in malaria treatment strategies. The pathway itself is not a single molecule and should not be mapped as a “receptor” but as a complex/critical metabolic pathway containing several protein moleculer targets, principally the HDP and associated digestive enzymes.[1][5][7]
Inhibition of hemozoin (malarial pigment) crystal formation - Complexation with free heme to prevent crystallization - Alkylation or binding to heme, causing toxic buildup of reactive oxygen species and cellular oxidative damage - Disruption of hemoglobin digestion-heme detoxification coupling
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium vivax heme detoxification pathway (None established).